Neuroprotection in Alzheimer's Disease

Illana Gozes* (Editor)

*Corresponding author for this work

Research output: Book/ReportBookpeer-review


Neuroprotection in Alzheimer's Disease offers a translational point-of-view from both basic and clinical standpoints, putting it on the cusp for further clinical development with its emphasis on nerve cell protection, including the accumulation of knowledge from failed clinical trials and new advances in disease management. This book brings together the latest findings, both basic, and clinical, under the same cover, making it easy for the reader to obtain a complete overview of the state-of-the-field and beyond. Alzheimer's disease is the most common form of dementia, accounting for 60 to 80 percent of dementia cases. It is a progressive brain disease that slowly destroys memory, thinking skills, and eventually, even the ability to carry out the simplest tasks. It is characterized by death of synapses coupled to death nerve cells and brain degeneration which is manifested by loss of cognitive abilities. Understanding neuroprotection in Alzheimer's disease will pave the path to better disease management and novel therapeutics. Comprehensive reference detailing neuroprotection in Alzheimer's Disease, with details on nerve cell protection and new advances in disease management Combines the knowledge and points-of-view of both medical doctors and basic scientists, putting the subject at the forefront for further clinical development Edited by one of the leading researchers in Alzheimer's Disease.

Original languageEnglish
Place of PublicationAmsterdam
PublisherElsevier Inc.
Number of pages325
ISBN (Electronic)9780128037126
ISBN (Print)9780128036907
StatePublished - 30 Dec 2016

ULI Keywords

  • uli
  • Alzheimer Disease -- prevention & control
  • Neuroprotection


Dive into the research topics of 'Neuroprotection in Alzheimer's Disease'. Together they form a unique fingerprint.

Cite this